Loading insider details...
Beta
Latest Form 4 (Sep 23, 2026): Sale of 87 OKUR shares, $258.76.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 23, 2026 | OnKure Therapeutics, Inc. (OKUR) | Sale | 87 | $258.76 |
| Aug 11, 2026 | OnKure Therapeutics, Inc. (OKUR) | Grant/Award | 150,000 | n/a |
| Jun 24, 2026 | OnKure Therapeutics, Inc. (OKUR) | Sale | 86 | $378.08 |
| Apr 3, 2026 | OnKure Therapeutics, Inc. (OKUR) | Grant/Award | 330,000 | n/a |
| Mar 24, 2026 | OnKure Therapeutics, Inc. (OKUR) | Sale | 86 | $357.46 |
| Dec 24, 2025 | OnKure Therapeutics, Inc. (OKUR) | Sale | 87 | $258.19 |
| Sep 24, 2025 | OnKure Therapeutics, Inc. (OKUR) | Sale | 88 | $230.87 |
| Jun 25, 2025 | OnKure Therapeutics, Inc. (OKUR) | Sale | 88 | $209.81 |
| Apr 8, 2025 | OnKure Therapeutics, Inc. (OKUR) | Sale | 358 | $1.2K |
| Jan 30, 2025 | OnKure Therapeutics, Inc. (OKUR) | Grant/Award | 130,000 | n/a |